30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Response Biomedical Corp (RBM)

Stock chart
Ticker: RBM


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
Wang Jonathan Jian
3 purchases — total 500,000 USD
Buy 16 Jun 2016
Value US$4,128,333.23 | Price 376.22 | Shares 14,846
Buy 16 Jun 2016
Value US$1,606,577.02 | Price 180.16 | Shares 48,636
Buy 16 Jun 2016
Value US$311,549.84 | Price 0.56 | Shares 556,339
Buy 16 Jun 2016
Value US$1,609,540.77 | Price 386.05 | Shares 27,985
Buy 16 Jun 2016
Value US$4,693,282.09 | Price 252.44 | Shares 16,246
Buy 16 Jun 2016
Value US$311,549.84 | Price 0.56 | Shares 556,339
Buy 16 Jun 2016
Value US$185,486.00 | Price 0.56 | Shares 331,225
Buy 16 Jun 2016
Value US$2,964.64 | Price 0.56 | Shares 5,294
Buy 16 Jun 2016
Value US$311,549.84 | Price 0.56 | Shares 556,339
Buy 25 Nov 2015
Value US$10,001.40 | Price 0.63 | Shares 15,800
Buy 17 Nov 2015
Value US$6,400.00 | Price 0.64 | Shares 10,000
Buy 17 Nov 2015
Value US$9,976.20 | Price 0.64 | Shares 15,600
Buy 19 Dec 2014
Value US$4,000.00 | Price 0.80 | Shares 5,000
Buy 4 Dec 2013
Value US$641.35 | Price 1.27 | Shares 505
Buy 3 Dec 2013
Value US$4,803.50 | Price 1.30 | Shares 3,695
Buy 29 Nov 2013
Value US$1,040.00 | Price 1.30 | Shares 800
Buy 7 Nov 2013
Value US$742,999.25 | Price 2.45 | Shares 303,265
Buy 7 Nov 2013
Value US$11,799.20 | Price 2.45 | Shares 4,816
Buy 7 Nov 2013
Value US$1,245,197.80 | Price 2.45 | Shares 508,244
Buy 19 Mar 2013
Value US$15,385.83 | Price 3.58 | Shares 4,300
Buy 15 Mar 2013
Value US$12,149.90 | Price 3.47 | Shares 3,500
Buy 12 Dec 2012
Value US$709.02 | Price 1.18 | Shares 600
Buy 30 Nov 2012
Value US$3,045.00 | Price 1.05 | Shares 2,900
Sale 28 Nov 2012
Value US$47,775.00 | Price 1.05 | Shares 45,500
Sale 28 Nov 2012
Value US$47,775.00 | Price 1.05 | Shares 45,500
Buy 28 Nov 2012
Value US$4,305.00 | Price 1.05 | Shares 4,100
Buy 30 Aug 2012
Value US$1,738.00 | Price 0.08 | Shares 22,000
Buy 30 Aug 2012
Value US$75.00 | Price 0.08 | Shares 1,000
Buy 30 Aug 2012
Value US$6,438.00 | Price 0.07 | Shares 87,000
Buy 29 Aug 2012
Value US$2,100.00 | Price 0.07 | Shares 30,000
Buy 24 Aug 2012
Value US$9,750.00 | Price 0.08 | Shares 130,000
Buy 16 Aug 2012
Value US$12,880.00 | Price 0.08 | Shares 161,000
Buy 15 Aug 2012
Value US$4,000.00 | Price 0.08 | Shares 50,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value
Number of shares Price Value Details
2016-06-20 2016-06-16 B Purchase Wang Jonathan Jian Non-Executive Director Large shareholder
14,846 +33.5%
376.22
US$4,128,333
14,846 +33.5% 376.22 US$4,128,333
2016-06-20 2016-06-16 B Purchase Wang Jonathan Jian Non-Executive Director Large shareholder
48,636 -22.3%
180.16
US$1,606,577
48,636 -22.3% 180.16 US$1,606,577
2016-06-20 2016-06-16 B Purchase Thompson Peter A. Non-Executive Director Large shareholder
27,985 +46.5%
386.05
US$1,609,541
27,985 +46.5% 386.05 US$1,609,541
2016-06-20 2016-06-16 B Purchase Thompson Peter A. Non-Executive Director Large shareholder
5,294 +18.3%
0.56
US$2,965
5,294 +18.3% 0.56 US$2,965
2016-06-20 2016-06-16 B Purchase ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
331,225 +18.2%
0.56
US$185,486
331,225 +18.2% 0.56 US$185,486
2016-06-20 2016-06-16 B Purchase ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
5,294 +18.3%
0.56
US$2,965
5,294 +18.3% 0.56 US$2,965
2016-06-20 2016-06-16 B Purchase Wang Jonathan Jian Non-Executive Director Large shareholder
556,339 +18.3%
0.56
US$311,550
556,339 +18.3% 0.56 US$311,550
2016-06-20 2016-06-16 B Purchase Thompson Peter A. Non-Executive Director Large shareholder
556,339 +18.3%
0.56
US$311,550
556,339 +18.3% 0.56 US$311,550
2016-06-20 2016-06-16 B Purchase ORBIMED ADVISORS LLC Non-Executive Director Large shareholder
556,339 +18.3%
0.56
US$311,550
556,339 +18.3% 0.56 US$311,550
2015-11-30 2015-11-25 B Purchase Adams William J.

CFO & Corporate Secretary

Officer
15,800 +49.8%
0.63
US$10,001
15,800 +49.8% 0.63 US$10,001
2015-11-19 2015-11-17 B Purchase Shuster Lewis Non-Executive Director
10,000 +14.6%
0.64
US$6,400
10,000 +14.6% 0.64 US$6,400
2015-11-19 2015-11-17 B Purchase Adams William J.

CFO & Corporate Secretary

Officer
15,600 +96.9%
0.64
US$9,976
15,600 +96.9% 0.64 US$9,976
2014-12-22 2014-12-19 B Purchase Adams William J.

CFO & Corporate Secretary

Officer
5,000 +45.0%
0.80
US$4,000
5,000 +45.0% 0.80 US$4,000
2013-12-05 2013-12-04 B Purchase PURVIN JEFFREY L

Chief Executive Officer

Executive Director
505 +5.7%
1.27
US$641
505 +5.7% 1.27 US$641
2013-12-05 2013-12-03 B Purchase PURVIN JEFFREY L

Chief Executive Officer

Executive Director
3,695 +72.5%
1.30
US$4,804
3,695 +72.5% 1.30 US$4,804
2013-12-05 2013-11-29 B Purchase PURVIN JEFFREY L

Chief Executive Officer

Executive Director
800 +18.6%
1.30
US$1,040
800 +18.6% 1.30 US$1,040
2013-11-12 2013-11-07 B Purchase ORBIMED ADVISORS LLC Large shareholder
303,265 +20.0%
2.45
US$742,999
303,265 +20.0% 2.45 US$742,999
2013-11-12 2013-11-07 B Purchase ORBIMED ADVISORS LLC Large shareholder
4,816 +19.9%
2.45
US$11,799
4,816 +19.9% 2.45 US$11,799
2013-11-12 2013-11-07 B Purchase ORBIMED ADVISORS LLC Large shareholder
508,244 +20.0%
2.45
US$1,245,198
508,244 +20.0% 2.45 US$1,245,198
2013-03-21 2013-03-19 B Purchase PURVIN JEFFREY L

Chief Executive Officer

Executive Director
4,300 +inf%
3.58
US$15,386
4,300 +inf% 3.58 US$15,386
2013-03-19 2013-03-15 B Purchase Adams William J.

CFO & Corporate Secretary

Officer
3,500 +46.1%
3.47
US$12,150
3,500 +46.1% 3.47 US$12,150
2012-12-14 2012-12-12 B Purchase Adams William J.

CFO & Corporate Secretary

Officer
600 +8.6%
1.18
US$709
600 +8.6% 1.18 US$709
2012-11-30 2012-11-30 B Purchase Adams William J.

CFO & Corporate Secretary

Officer
2,900 +70.7%
1.05
US$3,045
2,900 +70.7% 1.05 US$3,045
2013-12-12 2012-11-28 S Sale HOLLER ANTHONY F Non-Executive Director
45,500 -100.0%
1.05
US$47,775
45,500 -100.0% 1.05 US$47,775
2012-11-30 2012-11-28 S Sale HOLLER ANTHONY F Non-Executive Director
45,500 -100.0%
1.05
US$47,775
45,500 -100.0% 1.05 US$47,775
2012-11-30 2012-11-28 B Purchase Adams William J.

CFO & Corporate Secretary

Officer
4,100 +inf%
1.05
US$4,305
4,100 +inf% 1.05 US$4,305
2012-08-31 2012-08-30 B Purchase Shannon Timothy Patrick

SrVPWorldWideSales&Marketing

Officer
22,000 +8.9%
0.08
US$1,738
22,000 +8.9% 0.08 US$1,738
2012-08-31 2012-08-30 B Purchase Shannon Timothy Patrick

SrVPWorldWideSales&Marketing

Officer
1,000 +0.4%
0.08
US$75
1,000 +0.4% 0.08 US$75
2012-08-31 2012-08-30 B Purchase Shannon Timothy Patrick

SrVPWorldWideSales&Marketing

Officer
87,000 +54.4%
0.07
US$6,438
87,000 +54.4% 0.07 US$6,438
2012-08-31 2012-08-29 B Purchase Shannon Timothy Patrick

SrVPWorldWideSales&Marketing

Officer
30,000 +23.1%
0.07
US$2,100
30,000 +23.1% 0.07 US$2,100
2012-08-27 2012-08-24 B Purchase Shannon Timothy Patrick

SrVPWorldWideSales&Marketing

Officer
130,000 +inf%
0.08
US$9,750
130,000 +inf% 0.08 US$9,750
2012-08-17 2012-08-16 B Purchase PURVIN JEFFREY L

Chief Executive Officer

Executive Director
161,000 +322.0%
0.08
US$12,880
161,000 +322.0% 0.08 US$12,880
2012-08-17 2012-08-15 B Purchase PURVIN JEFFREY L

Chief Executive Officer

Executive Director
50,000 +inf%
0.08
US$4,000
50,000 +inf% 0.08 US$4,000
Explore more

More insider trading research around Response Biomedical Corp